Novartis Bioventures Ltd, 10% Owner at Celladon Corp (CLDN), bought 1,551,721 shares at $8.00 ($1.4M) on 2014-02-04, disclosed to the SEC on 2014-02-06.
Open-market purchase of $1.4M CLDN by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,372,798 | $0 | 0.0% |
| 2 | $8.00 | 16,537 | $132K | 9.2% |
| 3 | $8.00 | 162,386 | $1.3M | 90.8% |
| Total | $0.92 avg | 1,551,721 | $1.4M | 100% |
| Filing → |
| GRTX | SELL | 2020-06-04 | $251K | — | Filing → |
| BCYC | BUY | 2019-05-30 | $2.4M | — | Filing → |
| ARPO | SELL | 2019-04-15 | $185K | — | Filing → |